To provide a steadily increasing income stream by investing mainly in a range of UK equities.
Name | % Net Assets |
---|---|
BP | 6.5% |
Vodafone | 4.5% |
BAT | 4.3% |
GlaxoSmithKline | 4.2% |
Royal Dutch Shell | 3.9% |
BG | 3.8% |
HSBC | 3.5% |
AstraZeneca | 3.4% |
Anglo American | 3.2% |
Tullow Oil | 3.0% |
Key | % Net Assets |
---|---|
BP | 6.5% |
Vodafone | 4.5% |
BAT | 4.3% |
GlaxoSmithKline | 4.2% |
Other | 80.5% |
Date | 13-Nov-2024 |
---|---|
NAV | 817.13p |
Currency | GBP |
Change | -3.66p |
% | -0.45% |
YTD change | 46.06p |
YTD % | 5.97% |
Fund Inception | 23/04/1964 |
---|---|
Fund Manager | Richard Hughes |
TER | 1.66 (31-Dec-2013) |
Minimum Investment | |
---|---|
Initial | £500 |
Additional | £10 |
Savings | £10 |
Charges | |
---|---|
Initial | 4.00% |
Annual Mang't | 1.50% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.02 |
Sharpe ratio | 0.11 |
You are here: research